To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
CX516 is an ampakine compound that works as an AMPA modulator and is being devolped by a collaboration of Cortex and Shire and Servier. It is being pursued as a treatment for Alzheimer's disease, under the brand name Ampalex. It is also being examined as a treatment for ADHD. The CAS number of this compound is 154235-83-3.
Additional recommended knowledge
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "CX-516". A list of authors is available in Wikipedia.|